Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Choose Curebase for your upcoming study and enjoy enhanced diversity, accelerated enrollment, and improved patient retention. Our innovative methodology enables patients to participate from the comfort of their homes while being supported by community physicians, resulting in quicker, more cost-effective, and inclusive research studies. Curebase's distinct combination of in-house virtual Clinical Research Coordinators (CRCs) and a worldwide network of virtual Principal Investigators (PIs) collaborates seamlessly with local doctors to deliver studies directly to patients, no matter their location. Since many patients reside far from conventional research facilities, our trials effectively bring research into their homes and everyday medical environments, including local physician offices. Curebase's infectious disease trials successfully engage patients through a pioneering model that aligns with their needs, utilizing community healthcare and virtual environments, enabling broader participation in important clinical research. By leveraging technology and local connections, Curebase not only improves accessibility but also enhances the overall research experience for patients and providers alike.
Description
Specialty and rare diseases often encompass patient populations that are not clearly defined, including individuals who remain undiagnosed or face misdiagnoses, along with healthcare providers who may lack knowledge about these conditions and their various manifestations, resulting in treatment pathways that are poorly understood. IPM.ai operates as an Insights-as-a-Service (IaaS) firm, dedicated to empowering leading life sciences organizations to gain deeper insights into patient care and enhance the quality of life for those affected through the development, clinical research, and commercialization of therapeutic solutions. By predicting market size, analyzing the competitive landscape, and estimating potential return on investment, companies can optimize their commercialization strategies. Additionally, the platform identifies undiagnosed and misdiagnosed individuals who could benefit from early disease interception and therapeutic measures. It employs statistical models to gauge the prevalence of specific diseases within certain patient populations at any given moment. Furthermore, IPM.ai helps pinpoint physicians who are adept at diagnosing and treating these ideal patients, while also influencing other healthcare providers to enhance overall patient outcomes. This comprehensive approach ultimately aims to bridge the gap in understanding and addressing the needs of those with rare diseases.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Curebase
Founded
2017
Country
United States
Website
www.curebase.com
Vendor Details
Company Name
IPM.ai
Country
United States
Website
www.ipm.ai/platform
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning